Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 3 January 2003:
Vol. 299. no. 5603, p. 39
DOI: 10.1126/science.299.5603.39

News Focus

MICROBICIDES:
Raising New Barriers Against HIV Infection

Rebecca Spieler Trager

In January, the International Partnership for Microbicides (IPM), a nonprofit group dedicated to advancing a promising but undeveloped strategy for fighting HIV--using topical microbicides to block transmission--will open its doors. With $30 million in committed support, IPM intends to help evaluate an estimated 50 candidate compounds, clear barriers to testing, and facilitate access to microbicides that prove effective. IPM joins several other organizations supporting research in the area, but it will be the first to focus so intensely on coordinating microbicide R&D and reviewing products.

Read the Full Text



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Engineering of a Human Vaginal Lactobacillus Strain for Surface Expression of Two-Domain CD4 Molecules.
X. Liu, L. A. Lagenaur, P. P. Lee, and Q. Xu (2008)
Appl. Envir. Microbiol. 74, 4626-4635
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)